沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

已收盘 09-04 16:08:03

5.070

-0.070

-1.36%

最高5.205	最低5.005	成交量82.40万
今开5.140	昨收5.140	日振幅3.89%
总市值34.32亿	流通市值34.32亿	总股本6.77亿
成交额419.16万	换手率0.12%	流通股本6.77亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":5.07,"timestamp":1788509283011,"preClose":5.14,"halted":0,"volume":824000,"delay":0,"changeRate":-0.01361867704280144,"floatShares":677000000,"shares":677000000,"eps":-0.3570971840384495,"marketStatus":"已收盘","change":-0.07,"latestTime":"09-04 16:08:03","open":5.14,"high":5.205,"low":5.005,"amount":4191610,"amplitude":0.038911,"askPrice":5.155,"askSize":5000,"bidPrice":5.07,"bidSize":70000,"shortable":3,"etf":0,"ttmEps":-0.2468737949962366,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":5.14,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":2.323745,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2664238859","title":"【券商聚焦】交银国际：医药行业收入稳健增长 多重利好推动盈利表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238859","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238859?lang=zh_cn&edition=full","pubTime":"2026-09-04 09:00","pubTimestamp":1788483634,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，1H26港股/A股医药行业整体收入增长4.7%/3.2%。创新药产业链增速领跑行业，服务板块复苏：1）港股/A股CXO收入整体增长29.2%/25.3%，（扣非）净利润增长23.4%/67.6%，在各子板块中增速最快，行业整体景气度和订单需求处于高位。2）核心成药板块收入增长17.8%/3.4%、利润增长62.7%/35.0%。其中生物药增速远超化药，在板块收入中的占比也进一步提升。3）医院、器械、诊断、疫苗等板块业绩有复苏趋势。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02596","06996","IE00B5MMRT66.SGD","KURE","01177","02162","LU0315179316.USD","03759","LU1251922891.USD","SG9999004220.SGD","01093","09966","LU0856984785.SGD","BK1161","LU1152091168.USD","LU1242518857.USD","06990","09926","01951","01548","00013","03329","HK0000306685.HKD","BK1515","09996","BK1589","06160","KCE","LU0327786744.USD","LU1880383366.USD","01952","02096","01530","06078","LU0348783233.USD","03692","HK0000320264.USD","LU0588546209.SGD","01276","06821","01801","IE00B0JY6N72.USD","BK1209","LU0039217434.USD","IE00B543WZ88.USD","LU0307460666.USD","02268","02273","LU2543165471.USD","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880633","title":"股市必读：惠泰医疗新发布《关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664880633?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:52","pubTimestamp":1788457935,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司将于9月17日通过上证路演中心举办科创板医疗器械行业集体业绩说明会。公司公告汇总关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告深圳惠泰医疗器械股份有限公司将于2026年9月17日15:00–17:00通过上证路演中心网络互动方式参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会，就2026年半年度经营成果、财务状况等投资者关注问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617","BK1574","09996","BK1583","BK1100","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851806","title":"股市必读：新华医疗新发布《新华医疗关于公司产品获得三类和二类医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664851806?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:39","pubTimestamp":1788457149,"startTime":"0","endTime":"0","summary":"公司公告汇总新华医疗关于公司产品获得三类和二类医疗器械注册证的公告山东新华医疗器械股份有限公司近日获得国家药品监督管理局颁发的三类医疗器械注册证，产品为呼吸门控系统，型号RMS3，用于采集患者呼吸模式信息以实现CT影像与呼吸运动同步。子公司新华手术器械有限公司获得山东省药监局颁发的二类医疗器械注册证，产品为胸腔镜手术器械，由多种手术钳和吸引管组成，非无菌提供，适用于胸腔镜手术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0188","BK1574","BK1583","BK0028","09996","159883","BK1100","600587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870482","title":"科美诊断（688468）披露将参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会，9月3日股价下跌1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870482","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664870482?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:18","pubTimestamp":1788445098,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，科美诊断报收于6.34元，较前一交易日下跌1.4%，最新总市值为25.43亿元。该股当日开盘6.49元，最高6.5元，最低6.28元，成交额达1630.24万元，换手率为0.64%。近日，科美诊断技术股份有限公司发布关于参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会的公告。公告显示，公司将于2026年9月17日15:00-17:00通过上证路演中心网络文字互动方式参加该说明会。说明会后可通过上证路演中心查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688468","BK0239","09996","BK1100","159883","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704128","title":"山外山（688410）披露将参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会，9月3日股价下跌3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704128","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664704128?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:16","pubTimestamp":1788444979,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘，山外山报收于10.08元，较前一交易日下跌3.17%，最新总市值为45.1亿元。近日，重庆山外山血液净化技术股份有限公司发布公告称，公司将于2026年9月17日15:00-17:00参加科创板2026年半年度医疗器械及医疗设备行业集体业绩说明会，通过上证路演中心网络文字互动方式与投资者交流。投资者可于2026年9月4日至9月16日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过上证路演中心查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300042363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","BK1583","BK1100","688410","09996","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987559","title":"浩欧博(688656.SH)子公司获得13项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987559","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664987559?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:04","pubTimestamp":1788429879,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得13项由湖南省药品监督管理局核准签发的医疗器械注册证。上述医疗器械注册证的取得，进一步丰富了公司化学发光平台检测菜单，有助于提升公司市场综合竞争力，对公司及子公司的可持续性发展将产生积极影响和促进作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688656","AGNG","159883","BK1583","GDOC","IEIH","LGHT","LNGR","MDEV","MEDX","BK1100","HART","RSPH","PTH","BK1574","09996","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124444945","title":"沛嘉医疗-B更新2026年8月股份变动月报，股本上升至6.77亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1124444945","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124444945?lang=zh_cn&edition=full","pubTime":"2026-09-03 12:31","pubTimestamp":1788409883,"startTime":"0","endTime":"0","summary":"2026年9月3日，沛嘉医疗-B发布截至2026年8月31日的股份变动月报表。根据公告，公司的注册股本仍维持10万美元不变，股本面值为每股0.0001美元，总注册股本数量为10亿股普通股。公司当月无库藏股变动或回购注销计划，库藏股数量始终保持为0股。另有24,527,667份期权目前仍处于存续状态，6,463,130份购股权方案期权无新增或失效。公告还披露，公司已遵守香港联交所《上市规则》及相关法律法规，所有发行及转让事务均依法办理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845242","title":"股市必读：赛诺医疗新发布《赛诺医疗科学技术股份有限公司关于子公司产品获得国内医疗器械注册证的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845242","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845242?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:19","pubTimestamp":1788373150,"startTime":"0","endTime":"0","summary":"公司公告汇总：子公司赛诺神畅获颁输送型球囊扩张导管《医疗器械注册证》，适用于颅内动脉血管狭窄的球囊扩张处理，有效期至2031年8月30日。公司公告汇总赛诺医疗科学技术股份有限公司关于子公司产品获得国内医疗器械注册证的自愿性披露公告赛诺医疗控股子公司赛诺神畅收到国家药监局颁发的《医疗器械注册证》，产品名为输送型球囊扩张导管，注册证编号国械注准20263031844，有效期至2031年8月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK0251","09996","159883","688108","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214843","title":"股市必读：东方海洋新发布《关于全资子公司取得医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214843","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664214843?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:18","pubTimestamp":1788369493,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司艾维可生物取得清道夫受体-A测定试剂盒医疗器械注册证，有效期至2031年8月30日。公司公告汇总关于全资子公司取得医疗器械注册证的公告山东东方海洋科技股份有限公司全资子公司艾维可生物科技有限公司自主研发的清道夫受体-A测定试剂盒取得山东省药品监督管理局医疗器械注册证，注册证编号为鲁械注准20262400352，有效期至2031年8月30日，预期用途为体外定性测定人体血清、血浆中的清道夫受体-A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1100","159883","BK0046","BK0213","002086","09996","BK1574","BK0092"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664311810","title":"新华医疗（600587）披露公司产品获得三类和二类医疗器械注册证的公告，9月2日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664311810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664311810?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:41","pubTimestamp":1788360072,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，新华医疗报收于12.71元，较前一交易日下跌1.01%，最新总市值为77.1亿元。近日，山东新华医疗器械股份有限公司获得国家药品监督管理局颁发的三类医疗器械注册证，产品为呼吸门控系统，型号RMS3，用于采集患者呼吸模式信息以实现CT影像与呼吸运动同步。子公司新华手术器械有限公司获得山东省药监局颁发的二类医疗器械注册证，产品为胸腔镜手术器械，由多种手术钳和吸引管组成，非无菌提供，适用于胸腔镜手术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0188","600587","BK1100","BK1583","09996","159883","BK0251","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664816191","title":"【投融资动态】翌远生物天使轮融资，投资方为昆高新集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2664816191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664816191?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:25","pubTimestamp":1788348310,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于8月30日公布的信息整理，苏州翌远生物科技有限公司天使轮融资，融资额未披露，参与投资的机构包括昆高新集团。苏州翌远生物科技有限公司成立于2025年，公司主要经营第一类医疗器械生产；第一类医疗器械销售；第二类医疗器械销售；第二类医疗设备租赁；化妆品批发；化妆品零售；个人卫生用品销售；卫生用品和一次性使用医疗用品销售。数据来源：天眼查APP以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200037022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","BK1100","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818357","title":"鱼跃医疗：以AI重新定义医疗器械，向全场景数智健康管理服务商跃迁","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818357","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664818357?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:39","pubTimestamp":1788341980,"startTime":"0","endTime":"0","summary":"成果落地的时刻首先在具体成果上，2026年是鱼跃医疗AI+医疗创新成果密集落地的一年。从一款监测设备到一个代谢管理平台，鱼跃医疗所布局的已不局限于硬件本身，而是以生物传感器、可穿戴设备和AI应用为基础的长期健康管理体系。在这方面鱼跃医疗有着自己的洞察。综上，从AI嵌入到生态聚合，鱼跃医疗正在完成从“卖设备”到“建生态”的商业逻辑重构，从而在AI时代为自己构建新的核心壁垒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026090200031771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0197","BK0185","BK0188","BK0146","BK1100","BK0070","BK0114","002223","09996","159883","BK0251","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890538","title":"九强生物最新公告：取得叶酸测定试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890538","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890538?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:16","pubTimestamp":1788340607,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称，公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》，产品为叶酸测定试剂盒(磁微粒化学发光免疫分析法)，注册类别为Ⅱ类，有效期至2031年8月26日，用于体外定量测定人血清或血浆中叶酸含量。该注册证的取得丰富了公司在体外诊断化学发光细分领域产品线，有利于提升核心竞争力，但实际销售情况取决于市场推广效果，对业绩影响尚无法预测。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0046","BK0012","BK1100","159883","09996","300406","BK1574","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890827","title":"新华医疗最新公告：获呼吸门控系统及胸腔镜手术器械医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890827","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890827?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:40","pubTimestamp":1788338447,"startTime":"0","endTime":"0","summary":"新华医疗(600587.SH)公告称，公司近日收到国家药监局颁发的三类医疗器械注册证，产品为呼吸门控系统，用于采集病人呼吸模式信息给本公司CT设备，以获取与病人呼吸运动同步的影像；子公司新华手术器械获二类医疗器械注册证，产品为胸腔镜手术器械，与胸腔镜配套供胸腔镜手术使用。上述产品分别强化公司在精准放疗及微创腔镜手术领域的整体解决方案，丰富产品矩阵，提升综合竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200029334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","159883","BK1583","600587","BK0188","BK0028","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894673","title":"国金证券：双轮驱动医疗器械内外复苏 聚焦创新与出海主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664894673?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:25","pubTimestamp":1788333958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，医疗器械板块当前投资应紧扣“出海拓增量、创新守利润”的双轮驱动逻辑，同时把握国内需求复苏节奏。出海能有效分散集采风险，打开成长天花板，而持续的高强度研发投入则是维持高毛利率、抵御价格战的关键护城河。国金证券主要观点如下：医疗设备收入端同比稳定增长，毛利率略有承压。医疗耗材收入增速快速恢复，毛利率显著提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","600109","BK0201","LNGR","BK1583","IEIH","159883","LGHT","HART","BK0188","PTH","09996","BK0028","AGNG","MDEV","MEDX","BK0183","BK1574","GDOC","BK0012","RSPH","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899822","title":"港股异动 | 今海医疗科技(02225)涨超5% 上半年收益同比大幅增超1.3倍 战略重心转向高附加值医疗器械赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664899822?lang=zh_cn&edition=full","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上，近期，今海医疗科技披露2026年中期业绩。2026年上半年，集团实现收益3402.1万新加坡元，同比大幅增长134.16%，展现出强劲的销售增长动能。业务端，2026年上半年，公司收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IEIH","HART","BK4585","GDOC","BK1574","02225","VXUS","AGNG","09996","RSPH","BK1150","BK1583","KCAI","MDEV","LNGR","PTH","BK4588","BK1100","159883","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664042852","title":"东方海洋（002086）披露全资子公司取得医疗器械注册证公告，9月1日股价上涨3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664042852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664042852?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:21","pubTimestamp":1788272495,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，东方海洋报收于2.21元，较前一交易日上涨3.76%，最新总市值为43.29亿元。该股当日开盘2.14元，最高2.22元，最低2.14元，成交额达1.66亿元，换手率为4.77%。该产品获批丰富了公司在临床检测领域的产品线。目前该产品尚未投入生产，实际销售情况受市场拓展和需求等因素影响，对公司未来业绩的具体影响尚无法预测。公司提示投资者注意投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0092","002086","09996","159883","BK1100","BK0046","BK0213","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852110","title":"乐心医疗（300562）披露医疗器械CE证书延续注册公告，9月1日股价上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852110","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852110?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:16","pubTimestamp":1788272190,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，乐心医疗报收于18.97元，较前一交易日上涨5.56%，最新总市值为41.53亿元。乐心医疗近日披露《关于医疗器械注册证完成延续注册的公告》。公告显示，公司收到南德认证检测（中国）有限公司的回复，申请的电子血压计医疗器械CE符合性证书延续注册已获批准。证书编号为G15 082800 0052 Rev.00，注册分类为IIa类，延续后生效日期为2026年9月3日，到期日为2031年9月2日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300562","BK1583","BK0109","159883","BK1574","09996","BK1100","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852932","title":"透景生命（300642）披露取得6项医疗器械注册证公告，9月1日股价上涨19.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852932?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:04","pubTimestamp":1788271448,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，透景生命报收于20.35元，较前一交易日上涨19.99%，最新总市值为33.02亿元。该股当日开盘16.73元，最高20.35元，最低16.68元，成交额达8.07亿元，换手率为31.34%。公司于近日披露《关于取得医疗器械注册证的公告》。公告显示，上海透景生命科技股份有限公司及控股子公司上海脉示生物技术有限公司近日取得上海市药品监督管理局颁发的6项医疗器械注册证。注册证有效期均为2026年8月31日至2031年8月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","300642","BK1100","BK1574","BK1583","BK0239","BK0042","BK0046","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855470","title":"透景生命(300642.SZ)取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664855470?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:34","pubTimestamp":1788262475,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司及控股子公司上海脉示生物技术有限公司于近日取得上海市药品监督管理局颁发的6项医疗器械注册证。上述医疗器械注册证的取得，丰富了公司及子公司在多个技术平台的产品线布局，进一步完善公司在非肿瘤检测领域的业务布局，有利于提升公司整体品牌影响力和市场拓展能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GDOC","LGHT","MEDX","RSPH","BK1574","159883","HART","MDEV","BK0239","BK0042","BK1100","PTH","IEIH","AGNG","BK1583","LNGR","BK0046","09996","300642"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0629},{"period":"1month","weight":0.2866},{"period":"3month","weight":0.1297},{"period":"6month","weight":-0.1361},{"period":"1year","weight":-0.3376},{"period":"ytd","weight":-0.1448}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100991},{"month":4,"riseRate":0.8,"avgChangeRate":0.053778},{"month":5,"riseRate":0.6,"avgChangeRate":-0.096849},{"month":6,"riseRate":0.571429,"avgChangeRate":0.041819},{"month":7,"riseRate":0.571429,"avgChangeRate":0.044814},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.034075},{"month":9,"riseRate":0.285714,"avgChangeRate":0.012146},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}